Cargando…

Involvement of Cannabinoid Signaling in Vincristine-Induced Gastrointestinal Dysmotility in the Rat

Background: In different models of paralytic ileus, cannabinoid receptors are overexpressed and endogenous cannabinoids are massively released, contributing to gastrointestinal dysmotility. The antitumoral drug vincristine depresses gastrointestinal motility and a similar mechanism could participate...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vera, Gema, López-Pérez, Ana E., Uranga, José A., Girón, Rocío, Martín-Fontelles, Ma Isabel, Abalo, Raquel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2017
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5292571/ https://www.ncbi.nlm.nih.gov/pubmed/28220074 http://dx.doi.org/10.3389/fphar.2017.00037

Ejemplares similares

Fluoroscopic Characterization of Colonic Dysmotility Associated to Opioid and Cannabinoid Agonists in Conscious Rats
por: Díaz-Ruano, Susana, et al.
Publicado: (2019)

Effect of the Cannabinoid Agonist WIN 55,212-2 on Neuropathic and Visceral Pain Induced by a Non-Diarrheagenic Dose of the Antitumoral Drug 5-Fluorouracil in the Rat
por: Vera, Gema, et al.
Publicado: (2023)

Cardiovascular Toxicity Induced by Chronic Vincristine Treatment
por: Herradón, Esperanza, et al.
Publicado: (2021)

Current Treatment Options and Therapeutic Insights for Gastrointestinal Dysmotility and Functional Gastrointestinal Disorders
por: Singh, Rajan, et al.
Publicado: (2022)

Cannabinoid Drugs-Related Neuroprotection as a Potential Therapeutic Tool Against Chemotherapy-Induced Cognitive Impairment
por: Boullon, Laura, et al.
Publicado: (2021)

New Insights into the Understanding of Gastrointestinal Dysmotility
por: Ohlsson, Bodil, et al.
Publicado: (2007)

Gastrointestinal dysmotility in critically ill patients
por: Ladopoulos, Theodoros, et al.
Publicado: (2018)

Characterization of Cardiovascular Alterations Induced by Different Chronic Cisplatin Treatments
por: Herradón, Esperanza, et al.
Publicado: (2017)

Shugan Decoction Alleviates Colonic Dysmotility in Female SERT-Knockout Rats by Decreasing M(3) Receptor Expression
por: Wang, Yinshu, et al.
Publicado: (2020)

Activation of α7nAChR Protects Against Gastric Inflammation and Dysmotility in Parkinson’s Disease Rats
por: Zhou, Li, et al.
Publicado: (2021)

Factors associated with gastrointestinal dysmotility in critically ill patients
por: Petrović, Nemanja, et al.
Publicado: (2023)

Recent Advances in the Management of Severe Gastrointestinal Dysmotility
por: Vasant, Dipesh H, et al.
Publicado: (2021)

Pharmacokinetic Behavior of Vincristine and Safety Following Intravenous Administration of Vincristine Sulfate Liposome Injection in Chinese Patients With Malignant Lymphoma
por: Yang, Fen, et al.
Publicado: (2018)

Cannabinoid Modulation of Memory Consolidation in Rats: Beyond the Role of Cannabinoid Receptor Subtype 1
por: Ratano, Patrizia, et al.
Publicado: (2017)

Mast Cells and Gastrointestinal Dysmotility in the Cystic Fibrosis Mouse
por: De Lisle, Robert C., et al.
Publicado: (2009)

From Intestinal Permeability to Dysmotility: The Biobreeding Rat as a Model for Functional Gastrointestinal Disorders
por: Vanuytsel, Tim, et al.
Publicado: (2014)

Efficacy of Juzen-taiho-to against vincristine-induced toxicity in dogs
por: SHINOHARA, Yuta, et al.
Publicado: (2019)

Impact of Myenteric Plexus Alterations on Diabetes Related Gastrointestinal Dysmotility
por: Park, Kyung Sik
Publicado: (2013)

Gut Microbial Dysbiosis in the Pathogenesis of Gastrointestinal Dysmotility and Metabolic Disorders
por: Singh, Rajan, et al.
Publicado: (2021)

Mechanisms Underlying Gastrodin Alleviating Vincristine-Induced Peripheral Neuropathic Pain
por: Wang, Xiangyu, et al.
Publicado: (2021)

Cannabidiol and Other Non-Psychoactive Cannabinoids for Prevention and Treatment of Gastrointestinal Disorders: Useful Nutraceuticals?
por: Martínez, Vicente, et al.
Publicado: (2020)

Clinical Pharmacokinetics and Effects of Vincristine Sulfate in Dogs with Transmissible Venereal Tumor (TVT)
por: HANTRAKUL, Supannika, et al.
Publicado: (2014)

Expression of Luteinizing Hormone Receptor in the Gastrointestinal Tract in Patients with and without Dysmotility
por: Hammar, Oskar, et al.
Publicado: (2012)

Autoimmune Gastrointestinal Dysmotility in a Patient With HIV Treated With Methylprednisolone and Pyridostigmine
por: Gromisch, Christopher M., et al.
Publicado: (2021)

Vincristine Promotes Transdifferentiation of Fibroblasts Into Myofibroblasts via P38 and ERK Signal Pathways
por: Xu, Hui, et al.
Publicado: (2022)

Effects of Coffee and Its Components on the Gastrointestinal Tract and the Brain–Gut Axis
por: Iriondo-DeHond, Amaia, et al.
Publicado: (2020)

Dysmotility in Eosinophilic Esophagitis
por: Chai, Charmaine, et al.
Publicado: (2022)

Does Gastrointestinal Dysmotility Predispose to Recurrent or Severe Forms of Clostridium difficile Infections?
por: Hritani, Abdul wahab, et al.
Publicado: (2014)

AM-251, A Cannabinoid Antagonist, Modifies the Dynamics of Sleep–Wake Cycles in Rats
por: Bogáthy, Emese, et al.
Publicado: (2019)

Should oncologists trust cannabinoids?
por: Creanga-Murariu, Ioana, et al.
Publicado: (2023)

Editorial: Adverse Effects of Cancer Chemotherapy: Anything New to Improve Tolerance and Reduce Sequelae?
por: Nurgali, Kulmira, et al.
Publicado: (2018)

The Enteric Glia and Its Modulation by the Endocannabinoid System, a New Target for Cannabinoid-Based Nutraceuticals?
por: López-Gómez, Laura, et al.
Publicado: (2022)

Vincristine-Induced Peripheral Neuropathy in Childhood Acute Lymphoblastic Leukemia: Genetic Variation as a Potential Risk Factor
por: Yang, Qing-Yan, et al.
Publicado: (2021)

Esophageal Dysmotility in Gillespie Syndrome
por: Dell'Acqua Cassão, Bruna, et al.
Publicado: (2013)

Allergic Mastocytic Gastroenteritis and Colitis: An Unexplained Etiology in Chronic Abdominal Pain and Gastrointestinal Dysmotility
por: Akhavein M, A., et al.
Publicado: (2012)

Impact of Cannabis, Cannabinoids, and Endocannabinoids in the Lungs
por: Turcotte, Caroline, et al.
Publicado: (2016)

Emerging Role of (Endo)Cannabinoids in Migraine
por: Leimuranta, Pinja, et al.
Publicado: (2018)

Antitumor Cannabinoid Chemotypes: Structural Insights
por: Morales, Paula, et al.
Publicado: (2019)

Can Prescribed Cannabinoids Substitute Cannabis?
por: Batalla, A.
Publicado: (2022)

Editorial: Cancer therapy: The challenge of handling a double-edged sword
por: Nurgali, Kulmira, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_c905h6cfmb06r58pkovc8plo7c